Clinical Trial Update: Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and pharmacokinetics of oral OKN-007 in adults with recurrent high-grade glioma. The trial includes patients with glioblastoma mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma Multiforme
• High-grade Glioma
• Oligodendroglioma

Drugs mentioned

• OKN-007

Snippet

Sponsor: Oblato, Inc. | Conditions: High-grade Glioma, Oligodendroglioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING